Cargando…

Clinical characteristics and treatment outcomes of isolated myeloid sarcoma without bone marrow involvement: a single-institution experience

BACKGROUND: Isolated myeloid sarcoma (MS) is a rare extramedullary tumor mass composed of malignant myeloid precursor cells without any evidence of leukemia in the peripheral blood and bone marrow. We describe the clinical characteristics and outcomes of patients diagnosed with isolated MS at our in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jung Yeon, Chung, Haerim, Cho, Hyunsoo, Jang, Ji Eun, Kim, Yundeok, Kim, Soo-Jeong, Kim, Jin Seok, Hyun, Shin Young, Min, Yoo Hong, Cheong, June-Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641510/ https://www.ncbi.nlm.nih.gov/pubmed/29043233 http://dx.doi.org/10.5045/br.2017.52.3.184

Ejemplares similares

Decitabine as a First-Line Treatment for Older Adults Newly Diagnosed with Acute Myeloid Leukemia
por: Park, Hyunsung, et al.
Publicado: (2017)

Different roles of surveillance positron emission tomography according to the histologic subtype of non-Hodgkin’s lymphoma
por: Kim, Yu Ri, et al.
Publicado: (2021)

Arsenic trioxide synergistically promotes the antileukaemic activity of venetoclax by downregulating Mcl-1 in acute myeloid leukaemia cells
por: Cho, Hyunsoo, et al.
Publicado: (2021)

Pretreatment Epstein-Barr virus DNA in whole blood is a prognostic marker in peripheral T-cell lymphoma
por: Kim, Yu Ri, et al.
Publicado: (2017)

DRP1 Inhibition Enhances Venetoclax-Induced Mitochondrial Apoptosis in TP53-Mutated Acute Myeloid Leukemia Cells through BAX/BAK Activation
por: Jang, Ji Eun, et al.
Publicado: (2023)

Myeloperoxidase Expression in Acute Myeloid Leukemia Helps Identifying Patients to Benefit from Transplant
por: Kim, Yundeok, et al.
Publicado: (2012)

Immunosuppressive role of CD11b(+)CD33(+)HLA‐DR(−) myeloid‐derived suppressor cells‐like blast subpopulation in acute myeloid leukemia
por: Hyun, Shin Young, et al.
Publicado: (2020)

ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia
por: Hwang, Doh Yu, et al.
Publicado: (2020)

Aurora A kinase expression is increased in leukemia stem cells, and a selective Aurora A kinase inhibitor enhances Ara-C-induced apoptosis in acute myeloid leukemia stem cells
por: Kim, Soo-Jeong, et al.
Publicado: (2012)

HBsAg-Negative, Anti-HBc–Negative Patients Still Have a Risk of Hepatitis B Virus–Related Hepatitis after Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant Lymphoma
por: Park, Hyunsung, et al.
Publicado: (2018)

Predictive Factors of Event-Free Survival at 24 Months in Patients with Peripheral T-Cell Lymphoma: A Retrospective Study
por: Kim, Yu Ri, et al.
Publicado: (2022)

Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based Regimens
por: Hyun, Shin Young, et al.
Publicado: (2016)

All-Trans Retinoic Acid Synergizes with Enasidenib to Induce Differentiation of IDH2-Mutant Acute Myeloid Leukemia Cells
por: Kim, Yundeok, et al.
Publicado: (2020)

The Modified Glasgow Prognostic Scores as a Predictor in Diffuse Large B Cell Lymphoma Treated with R-CHOP Regimen
por: Kim, Yundeok, et al.
Publicado: (2014)

Cytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myeloma
por: Ha, Jihye, et al.
Publicado: (2022)

PERK/NRF2 and autophagy form a resistance mechanism against G9a inhibition in leukemia stem cells
por: Jang, Ji Eun, et al.
Publicado: (2020)

Clinical significance of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
por: Kim, Jin Seok, et al.
Publicado: (2011)

A Case of Histiocytic Sarcoma Presenting with Primary Bone Marrow Involvement
por: Sohn, Byeong Seok, et al.
Publicado: (2010)

Enhanced autophagy in cytarabine arabinoside-resistant U937 leukemia cells and its potential as a target for overcoming resistance
por: CHEONG, JUNE-WON, et al.
Publicado: (2016)

Karyotypic change between diagnosis and relapse as a predictor of salvage therapy outcome in AML patients
por: Kim, Yundeok, et al.
Publicado: (2013)

Serum microRNA-21 as a Potential Biomarker for Response to Hypomethylating Agents in Myelodysplastic Syndromes
por: Kim, Yundeok, et al.
Publicado: (2014)

Widespread myeloid sarcoma with KMT2A rearrangement involving the testis, oral cavity, heart, kidney and gallbladder without bone marrow involvement
por: Kapur, Rohan, et al.
Publicado: (2022)

P800: CHARACTERIZATION OF REGULATORY T CELLS IN PATIENTS WITH MULTIPLE MYELOMA
por: Kim, Sojeong, et al.
Publicado: (2023)

High rate of hepatitis B reactivation during tyrosine kinase inhibitor treatment among patients with chronic myeloid leukemia in Korea
por: Kong, Jee Hyun, et al.
Publicado: (2022)

A rare case of isolated myeloid sarcoma of the small gut with inv(16)(p13;q22) without bone marrow involvement
por: Mandal, Prakas Kumar, et al.
Publicado: (2014)

Temporal Bone Myeloid Sarcoma
por: Chang, Ki-Hong, et al.
Publicado: (2009)

Targeted next generation sequencing can serve as an alternative to conventional tests in myeloid neoplasms
por: Kim, Borahm, et al.
Publicado: (2019)

Granulocytic sarcoma of the breast without development of bone marrow involvement: a case report
por: Vela-Chávez, Teresa A, et al.
Publicado: (2009)

Myeloid Sarcoma Involving the Testicular Vein
por: Filizoğlu, Nuh, et al.
Publicado: (2021)

Programmed cell death 1 expression is associated with inferior survival in patients with primary central nervous system lymphoma
por: Cho, Hyunsoo, et al.
Publicado: (2017)

Analysis of PET parameters predicting response to radiotherapy for myeloid sarcoma
por: Choi, Kyu Hye, et al.
Publicado: (2021)

RTK-RAS pathway mutation is enriched in myeloid sarcoma
por: Choi, Mihong, et al.
Publicado: (2018)

Distinct Clinical Characteristics of Unplanned Excision in Synovial Sarcoma
por: Choi, Eun Seok, et al.
Publicado: (2015)

Granulocytic Sarcoma in Breast after Bone Marrow Transplantation
por: Kim, Seung Jin, et al.
Publicado: (2013)

Widespread myeloid sarcomas in a patient in morphological remission in the bone marrow
por: Vidler, Jennifer, et al.
Publicado: (2021)

Therapy-Related Myeloid Neoplasms in 39 Korean Patients: A Single Institution Experience
por: Huh, Hee Jae, et al.
Publicado: (2013)

Radiotherapy as an effective treatment modality for follicular lymphoma: a single institution experience
por: Choi, Seo Hee, et al.
Publicado: (2015)

Outcome of Intensive Therapy for Children with Relapsed Acute Myeloid Leukemia: A Single Institution Korean Study
por: Lee, Jae Wook, et al.
Publicado: (2022)

Demographics, Changes in Treatment Patterns, and Outcomes of Bone and Soft Tissue Sarcomas in Korea—A Sarcoma-Specific, Institutional Registry-Based Analysis
por: Jeong, Hyehyun, et al.
Publicado: (2021)

Progressive cranial neuropathy and uterine involvement in myeloid sarcoma
por: Khoo, Anthony, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4rjs9920uru50l0ektrr2o5ot0